Acute Haematological Variations in Patients Receiving Radiotherapy and its Correlation with Volume of the Bone Marrow and Radiation Dose

Rajesh Javarappa
{"title":"Acute Haematological Variations in Patients Receiving Radiotherapy and its Correlation with Volume of the Bone Marrow and Radiation Dose","authors":"Rajesh Javarappa","doi":"10.30683/1927-7229.2020.09.10","DOIUrl":null,"url":null,"abstract":": Purpose: Radiation treatment of all malignancies inevitably includes certain percentage of bone marrow in the site and volume of irradiation. The purpose is to study the magnitude of radiation induced early haematological toxicity in relation to the total dose and volume of the marrow in the field of irradiation. Materials & Methods: A Prospective analysis was done in 60 patients treated with telecobalt. Haemoglobin, WBC and platelet counts were done before starting treatment and then weekly till the completion of treatment. The volume of bone marrow in the radiation fields was also recorded. Results: The haemoglobin percentage change between baseline and 5 th week was 5.19%(p=0.026) and7.35% (p=0.049) in <5%, 5-20% &>20% of bone marrow irradiated respectively. The percentage of change between baseline and 5 th week total WBC count was 23.79% (p=0.000), 35.53% (p=0.006) and 27.90% (p=0.000) in <5%, 5-20% &>20% of bone marrow irradiated respectively. The percentage change in platelets between baseline and 5 th week of 22.14%, 24.66% & 24.80% in patients with <5%, 5-20% and >20% of bone marrow irradiated respectively (overall p=0.000). Conclusion: The percentage of active bone marrow in the field of irradiation, dose per fraction and the total dose received are the best parameters for the study of haematological variations in patients being treated with radiotherapy. There is significant Haematological variations with decreasing trend in relation to volume of bone marrow irradiated and radiation dose.","PeriodicalId":14957,"journal":{"name":"Journal of Analytical Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Analytical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30683/1927-7229.2020.09.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Purpose: Radiation treatment of all malignancies inevitably includes certain percentage of bone marrow in the site and volume of irradiation. The purpose is to study the magnitude of radiation induced early haematological toxicity in relation to the total dose and volume of the marrow in the field of irradiation. Materials & Methods: A Prospective analysis was done in 60 patients treated with telecobalt. Haemoglobin, WBC and platelet counts were done before starting treatment and then weekly till the completion of treatment. The volume of bone marrow in the radiation fields was also recorded. Results: The haemoglobin percentage change between baseline and 5 th week was 5.19%(p=0.026) and7.35% (p=0.049) in <5%, 5-20% &>20% of bone marrow irradiated respectively. The percentage of change between baseline and 5 th week total WBC count was 23.79% (p=0.000), 35.53% (p=0.006) and 27.90% (p=0.000) in <5%, 5-20% &>20% of bone marrow irradiated respectively. The percentage change in platelets between baseline and 5 th week of 22.14%, 24.66% & 24.80% in patients with <5%, 5-20% and >20% of bone marrow irradiated respectively (overall p=0.000). Conclusion: The percentage of active bone marrow in the field of irradiation, dose per fraction and the total dose received are the best parameters for the study of haematological variations in patients being treated with radiotherapy. There is significant Haematological variations with decreasing trend in relation to volume of bone marrow irradiated and radiation dose.
放疗患者急性血液学变化及其与骨髓体积和放疗剂量的关系
目的:所有恶性肿瘤的放射治疗不可避免地包括一定比例的骨髓照射部位和照射体积。目的是研究辐射诱发的早期血液学毒性的大小与照射场中骨髓的总剂量和体积的关系。材料与方法:对60例接受远程钴治疗的患者进行前瞻性分析。在开始治疗前进行血红蛋白、白细胞和血小板计数,然后每周进行一次,直到治疗完成。骨髓在辐射场中的体积也被记录下来。结果:20%的骨髓放射组血红蛋白与基线和第5周相比变化率分别为5.19%(p=0.026)和7.35% (p=0.049)。基线至第5周总白细胞计数变化百分比分别为23.79% (p=0.000)、35.53% (p=0.006)和27.90% (p=0.000)。在接受20%骨髓放疗的患者中,血小板从基线到第5周的百分比变化分别为22.14%、24.66%和24.80%(总体p=0.000)。结论:骨髓在放射场中的活性百分率、每分数剂量和总剂量是研究放疗患者血液学变化的最佳参数。血液学变化明显,随骨髓辐照量和辐照剂量的增加呈下降趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信